![Mark Rubinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 270 468 $ am 31.10.2026
Mark L.
Rubinstein is Chief Medical Officer at Achieve Life Sciences, Inc. starting in 2025.
Formerly, Dr. Rubinstein was Head-Medical Affairs at Blip Products, Inc. Education includes a doctorate from Yale University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.01.2026 | 39.600 ( 0,04 % ) | 270 468 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACHIEVERX, THE QUIT COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Blip Products, Inc.
 Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Blip Products, Inc.
Blip Products, Inc. Pharmaceuticals: MajorHealth Technology Produces and sells nicotine replacement therapy products through online | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen
